CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,827,401 | -28.5% | 40,260 | +141.2% | 0.02% | -33.3% |
| Q4 2020 | $2,556,000 | +84.9% | 16,695 | +1.0% | 0.02% | +60.0% |
| Q3 2020 | $1,382,000 | +13.8% | 16,525 | 0.0% | 0.02% | +7.1% |
| Q2 2020 | $1,214,000 | +77.2% | 16,525 | +2.3% | 0.01% | +40.0% |
| Q1 2020 | $685,000 | -30.4% | 16,150 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $984,000 | -44.3% | 16,150 | -62.5% | 0.01% | -47.8% |
| Q3 2019 | $1,766,000 | -13.0% | 43,090 | 0.0% | 0.02% | -11.5% |
| Q2 2019 | $2,030,000 | +190.4% | 43,090 | +120.3% | 0.03% | +188.9% |
| Q1 2019 | $699,000 | – | 19,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |